By Peter A. McCullough, MD, MPH
Many of our readers have wondered why about ~25% of adult Americans take statins. The weakest case for statins would be treatment of adults with no history of atherosclerotic cardiovascular disease. This report from Chou et al for the US Preventative Services Task Force, historically a very conservative guidelines body, gives the evidence from 19 randomized trials involving 71,344 participants.
The results clearly demonstrated the following significant reductions after treatment for ~2 years:
-
14% reduction in all cause mortality
-
18% reduction in cardiovascular mortality
-
29% reduction in stroke
-
36% reduction in myocardial infarction
Click this link for the original source of this article.
Author: Peter McCullough, MD
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.